Lars A Akslen Selected Research

1- stearoyl- 2- linoleoylphosphatidylcholine

1/2022

Detection and significance of small and low proliferation breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lars A Akslen Research Topics

Disease

100	Neoplasms (Cancer) 01/2022 - 04/2002
43	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2004
32	Endometrial Neoplasms (Endometrial Cancer) 01/2018 - 04/2002
24	Melanoma (Melanoma, Malignant) 09/2020 - 12/2002
19	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2003
14	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 12/2002
9	Carcinoma (Carcinomatosis) 01/2022 - 04/2003
7	Hypoxia (Hypoxemia) 01/2021 - 12/2008
5	Necrosis 01/2019 - 05/2008
5	Aneuploidy (Aneuploid) 02/2017 - 02/2008
5	Papillary Thyroid Cancer 11/2011 - 08/2002
4	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2021 - 03/2008
4	Disease Progression 06/2020 - 06/2009
4	Hyperplasia 10/2019 - 06/2009
4	Carcinogenesis 03/2013 - 06/2008
3	Lung Neoplasms (Lung Cancer) 10/2017 - 10/2009
3	Ovarian Neoplasms (Ovarian Cancer) 03/2016 - 02/2009
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2014 - 06/2008
3	Nevus (Nevi) 03/2014 - 12/2005
3	Lymphatic Metastasis 11/2013 - 10/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 05/2009
2	Inflammation (Inflammations) 01/2018 - 11/2015
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 08/2017
2	Endometrial Hyperplasia 09/2017 - 03/2013
2	Hypertension (High Blood Pressure) 08/2017 - 01/2012
2	Adenocarcinoma 02/2014 - 11/2013

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2004
23	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2006
15	Estrogen ReceptorsIBA 09/2021 - 10/2003
14	Cadherins (E-Cadherin)IBA 10/2019 - 04/2004
12	Phenobarbital (Luminal)FDA Link 09/2021 - 08/2004
11	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 01/2003
10	Hormones (Hormone)IBA 07/2020 - 10/2002
10	Messenger RNA (mRNA)IBA 01/2020 - 08/2002
9	Keratin-5 (Keratin 5)IBA 01/2017 - 10/2003
8	DNA (Deoxyribonucleic Acid)IBA 09/2017 - 10/2002
7	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2012
7	ParaffinIBA 01/2020 - 04/2004
6	ErbB Receptors (EGF Receptor)IBA 01/2022 - 02/2008
5	Factor VIII (Coagulation Factor VIII)IBA 01/2021 - 11/2003
5	StathminIBA 01/2020 - 10/2010
5	Biological ProductsIBA 12/2019 - 08/2002
5	Tumor Biomarkers (Tumor Markers)IBA 11/2018 - 04/2002
5	Progesterone Receptors (Progesterone Receptor)IBA 12/2017 - 12/2007
5	AntibodiesIBA 04/2017 - 08/2004
4	Pharmaceutical PreparationsIBA 01/2022 - 06/2008
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2015 - 11/2006
4	Keratins (Keratin)IBA 04/2015 - 08/2004
4	Complementary DNA (cDNA)IBA 01/2014 - 08/2002
4	Phosphotransferases (Kinase)IBA 01/2014 - 06/2008
4	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2012 - 01/2003
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2020 - 01/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 06/2020 - 01/2014
3	Indicators and Reagents (Reagents)IBA 01/2019 - 04/2010
3	NestinIBA 01/2017 - 06/2009
3	Thrombospondin 1IBA 03/2016 - 07/2009
3	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2013 - 10/2010
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013 - 02/2006
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2012 - 06/2008
3	beta CateninIBA 03/2006 - 04/2004
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 05/2009
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 08/2009
2	Monoclonal AntibodiesIBA 06/2020 - 01/2020
2	IntegrinsIBA 01/2020 - 02/2006
2	Axl Receptor Tyrosine KinaseIBA 01/2020 - 01/2016
2	CarbohydratesIBA 12/2019 - 11/2019
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 10/2019 - 01/2014
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2019 - 10/2017
2	Sunitinib (Sutent)FDA Link 01/2018 - 08/2017
2	OligonucleotidesIBA 09/2017 - 02/2009
2	Peptides (Polypeptides)IBA 03/2016 - 05/2013
2	HSP27 Heat-Shock ProteinsIBA 01/2016 - 05/2012
2	Fluorouracil (Carac)FDA LinkGeneric 10/2015 - 11/2006
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 10/2015 - 11/2006
2	ChromograninsIBA 04/2015 - 10/2009
2	NucleotidesIBA 02/2014 - 02/2006
2	MTOR InhibitorsIBA 02/2014 - 03/2013
2	Estrogen Receptor alphaIBA 09/2009 - 11/2008
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2009 - 01/2003
2	Cell Adhesion MoleculesIBA 12/2008 - 12/2007
2	OsteopontinIBA 12/2008 - 02/2006
2	Angiogenesis InhibitorsIBA 05/2006 - 08/2004
2	Vascular Endothelial Growth Factor CIBA 03/2006 - 01/2003
2	Polycomb-Group ProteinsIBA 02/2006 - 01/2006
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2006 - 01/2006
2	Codon (Codons)IBA 09/2005 - 08/2005
2	Cyclin EIBA 06/2005 - 02/2004
2	Cyclin D1IBA 12/2004 - 02/2004
2	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 12/2004 - 04/2002
2	guanosine 5'-monophosphorothioateIBA 01/2003 - 12/2002
1	1- stearoyl- 2- linoleoylphosphatidylcholineIBA 01/2022
1	CollagenIBA 01/2022

Therapy/Procedure

26	Therapeutics 01/2022 - 01/2006
7	Drug Therapy (Chemotherapy) 01/2021 - 11/2006
5	Prostatectomy (Retropubic Prostatectomy) 10/2019 - 04/2003
4	Curettage 11/2013 - 10/2006
3	Castration 01/2021 - 06/2009
3	Hysterectomy 05/2011 - 02/2008
2	Radiotherapy 01/2021 - 11/2013
2	Neoadjuvant Therapy 01/2014 - 11/2006